PERIsign - Objective assessment of peritonitis
| Reference number | |
| Coordinator | STB INN AB |
| Funding from Vinnova | SEK 300 000 |
| Project duration | April 2021 - April 2022 |
| Status | Completed |
| Venture | Innovative Startups |
| Call | Innovative Startups step 1 spring 2021 |
Important results from the project
** Denna text är maskinöversatt ** With help from the Innovativa Start-up step 1 program, PERIsign has moved from an early idea stage to a clear product. PERIsign is now market-verified and the technical solutions are verified. In the project, PERIsign has developed a working first prototype together with Chalmers Tekniska Högskola and applied for a patent for the product.
Expected long term effects
** Denna text är maskinöversatt ** The project has been fundamental to PERIsign´s development. We have moved from an idea to a clear product. The project has enabled continued development and we are now in the starting pits to raise external capital and continue the development of PERIsign. We are planning another iteration of proof of concept and then a prototype for clinical evaluation 2022. 2023-2024, we expect that a first version of PERIsign is ready for market.
Approach and implementation
* Denna text är maskinöversatt The project was divided into 4 activities. 1. Patent application - Completed according to plan, submitted according to the PCT system. 2. Complete a prototype/proof of concept - According to plan, final reported in June 2021 as part of a degree project at Chalmers University. 3. Regulatory evaluation/strategy planning - According to plan, resulting in basic strategy in our product development and planning for clinical evaluation. 4. Market verification - According to plan, contributed strongly to interest in the product and ensures continued interest.